{
    "clinical_study": {
        "@rank": "3068", 
        "arm_group": {
            "arm_group_label": "Near-infrared spectroscopy sensors", 
            "description": "Term infants born by elective Caesarean section"
        }, 
        "brief_summary": {
            "textblock": "Regional tissue oxygenation (cStO2) can be monitored by near infrared spectroscopy. The\n      commercial device INVOS 5100 (COVIDIEN, Mansfield, MA, USA) and the prototype OxyPrem vs.\n      1.2 (Biomedical Optics Research Laboratory, Zurich, Switzerland) will be used simultaneously\n      to test for their relative sensitivity for low oxygen levels just after birth on term\n      infants born by elective caesarean section. Reproducibility will be examined by replacements\n      of the sensors six times the next day when the infant is stable and quiet. The Adult\n      Somasensor (INVOS) will be used together with the OxyPrem sensor."
        }, 
        "brief_title": "Cerebral Oximetry in Newborns - Comparing INVOS 5100c and OxyPrem vs. 1.2", 
        "completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "condition": "Near-infrared Spectroscopy, Transition, Caesarean Section", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Term infants\n\n          -  Elective caesarean section\n\n        Exclusion Criteria:\n\n          -  Thick hair that makes good measurements difficult/impossible\n\n          -  obvious malformations or syndromes\n\n          -  Complications in relation to caesarean section\n\n          -  Depression after birth (APGAR < 8 after 1 minute)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "10 Minutes", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Healthy term infants born by elective caesarean section at Rigshospitalet, Denmark"
            }
        }, 
        "enrollment": {
            "#text": "24", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 16, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01771601", 
            "org_study_id": "090113OXYVOS"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Near-infrared spectroscopy, cerebral oxygenation, term newborn, reproducibility,", 
        "lastchanged_date": "September 30, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Copenhagen", 
                    "country": "Denmark", 
                    "zip": "2100"
                }, 
                "name": "Gorm Greisen"
            }
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_groups": "1", 
        "official_title": "Cerebral Oximetry in Newborns - Comparing INVOS 5100c and OxyPrem vs. 1.2's Absolute Values, Sensitivity for Low Oxygen Levels and Reproducibility", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "Denmark: Danish Health and Medicines Authority", 
                "Denmark: The regional Danish ethical committee", 
                "Denmark: The Danish Data protection agency"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The sensors of both instruments will be placed on each side of the head. They will be held by hand by self-adhesive tape as appropriate.", 
            "measure": "Cerebral oxygenation", 
            "safety_issue": "No", 
            "time_frame": "10 minutes"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01771601"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Rigshospitalet, Denmark", 
            "investigator_full_name": "Gorm Greisen", 
            "investigator_title": "professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "The sensor will be placed 6 times alternating on each frontoparietal region and held by hand, obtaining 30 seconds of signal for each placement. The placements will be in the same region but not in exactly the same spot. This will be done for both devices.", 
            "measure": "Reproducibility", 
            "safety_issue": "No", 
            "time_frame": "10 minutes"
        }, 
        "source": "Rigshospitalet, Denmark", 
        "sponsors": {
            "collaborator": {
                "agency": "The Augustinus Foundation, Denmark.", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Rigshospitalet, Denmark", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "September 2013"
    }
}